JPWO2023120643A1 - - Google Patents

Info

Publication number
JPWO2023120643A1
JPWO2023120643A1 JP2023569535A JP2023569535A JPWO2023120643A1 JP WO2023120643 A1 JPWO2023120643 A1 JP WO2023120643A1 JP 2023569535 A JP2023569535 A JP 2023569535A JP 2023569535 A JP2023569535 A JP 2023569535A JP WO2023120643 A1 JPWO2023120643 A1 JP WO2023120643A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023569535A
Other languages
Japanese (ja)
Other versions
JPWO2023120643A5 (cg-RX-API-DMAC7.html
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2023120643A1 publication Critical patent/JPWO2023120643A1/ja
Publication of JPWO2023120643A5 publication Critical patent/JPWO2023120643A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/195—Chemokines, e.g. RANTES
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/522—Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2023569535A 2021-12-23 2022-12-22 Pending JPWO2023120643A1 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021209975 2021-12-23
PCT/JP2022/047366 WO2023120643A1 (ja) 2021-12-23 2022-12-22 Cxcr3発現細胞遊走活性が増強したcxcr3リガンド。

Publications (2)

Publication Number Publication Date
JPWO2023120643A1 true JPWO2023120643A1 (cg-RX-API-DMAC7.html) 2023-06-29
JPWO2023120643A5 JPWO2023120643A5 (cg-RX-API-DMAC7.html) 2025-11-28

Family

ID=86902738

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023569535A Pending JPWO2023120643A1 (cg-RX-API-DMAC7.html) 2021-12-23 2022-12-22

Country Status (5)

Country Link
US (1) US20250073307A1 (cg-RX-API-DMAC7.html)
EP (1) EP4455158A4 (cg-RX-API-DMAC7.html)
JP (1) JPWO2023120643A1 (cg-RX-API-DMAC7.html)
CN (1) CN118660904A (cg-RX-API-DMAC7.html)
WO (1) WO2023120643A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3892330A4 (en) 2018-12-04 2022-10-26 Chugai Seiyaku Kabushiki Kaisha CXCR3 LIGAND

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003082335A1 (fr) * 2002-04-03 2003-10-09 Sumitomo Pharmaceuticals Co., Ltd. Nouveau dispositif de controle du sucre dans le sang et procede de criblage associe
JP2008545396A (ja) * 2005-05-18 2008-12-18 インターミューン インコーポレイテッド 非天然ケモカイン受容体リガンドおよびこれらの使用方法
WO2020116498A1 (ja) * 2018-12-04 2020-06-11 中外製薬株式会社 Cxcr3リガンド
WO2021038033A1 (en) * 2019-08-29 2021-03-04 Antagonis Biotherapeutics Gmbh T-cell mobilizing cxcl10 mutant with increased glycosaminoglycan binding affinity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017364818C1 (en) 2016-11-28 2025-05-15 Chugai Seiyaku Kabushiki Kaisha Ligand-binding molecule having adjustable ligand binding activity
KR20200089312A (ko) 2017-11-28 2020-07-24 추가이 세이야쿠 가부시키가이샤 리간드 결합 활성을 조정 가능한 리간드 결합 분자
KR20250134208A (ko) 2017-11-28 2025-09-09 추가이 세이야쿠 가부시키가이샤 항원 결합 도메인 및 운반 부분을 포함하는 폴리펩티드

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003082335A1 (fr) * 2002-04-03 2003-10-09 Sumitomo Pharmaceuticals Co., Ltd. Nouveau dispositif de controle du sucre dans le sang et procede de criblage associe
JP2008545396A (ja) * 2005-05-18 2008-12-18 インターミューン インコーポレイテッド 非天然ケモカイン受容体リガンドおよびこれらの使用方法
WO2020116498A1 (ja) * 2018-12-04 2020-06-11 中外製薬株式会社 Cxcr3リガンド
WO2021038033A1 (en) * 2019-08-29 2021-03-04 Antagonis Biotherapeutics Gmbh T-cell mobilizing cxcl10 mutant with increased glycosaminoglycan binding affinity

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CAMPANELLA, G.S.V., ET AL.: ""CXCR3 and heparin binding sites of the chemokine IP-10 (CXCL10)."", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 278, no. 19, JPN6023009611, 9 May 2003 (2003-05-09), pages 17066 - 17074, ISSN: 0005907492 *
GERLZA, T., ET AL.: ""Designing an improved T-cell mobilising CXCL10 mutant through enhanced GAG binding affinity."", PROTEIN ENGINEERING, DESIGN AND SELECTION, vol. 32, no. 8, JPN7023000972, 23 January 2020 (2020-01-23), pages 367 - 373, ISSN: 0005907491 *

Also Published As

Publication number Publication date
WO2023120643A1 (ja) 2023-06-29
EP4455158A1 (en) 2024-10-30
EP4455158A4 (en) 2026-04-15
CN118660904A (zh) 2024-09-17
US20250073307A1 (en) 2025-03-06

Similar Documents

Publication Publication Date Title
BR102022018833B1 (pt) Método para monitorar um catalisador de oxidação, sistema para monitorar um catalisador de oxidação e sistema para monitorar um catalisador de oxidação para um motor de combustão interna de queima pobre
CN306623117S (zh) 吸顶灯(现代-双环)
CN306623668S (zh) 内衣(2152)
CN306624267S (zh) 笔套(京师二代)
CN306624237S (zh) 抽屉盒
CN306623363S (zh) 脚皮刨刀(21023)
CN306636282S (zh) 茶具包装盒(1)
CN306636065S (zh) 瓶子(5l)
CN306636279S (zh) 面膜包装盒(葡萄酒)
CN306610179S (zh) 泵头(3)
CN306612292S (zh) 智能搜救信标
CN306597390S (zh) 投影镜头固定座
CN306580438S (zh) 文档拍摄仪(CZUR Lens)
CN306594569S (zh) 茶水桶(yh-007-1)
CN306593198S (zh) 茶水桶
CN306593989S (zh) 包装盒(冻龙虾)
CN306172668S (zh) 茶漏
CN306173735S (zh) 垃圾箱(集装箱创意小号)
CN306131210S (zh) 游戏套装(玩具)
CN306156987S (zh) 平衡车训练场覆盖层(夺旗竞速赛)
CN306184657S (zh) 按摩器(颈挂式)
CN306156775S (zh) 消毒柜
CN306174466S (zh) 工程船
CN306157052S (zh) 车路协同多功能信息杆柱(淀波)
CN306172629S (zh) 拾取和推动食物的手动叉

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251118

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20251118

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20260706

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260713